ArticleMolecular cell2026
Structural basis for RISC assembly of human Argonaute2.
Article in Molecular cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Central guide-target pairing activates human Argonaute2 by uncoupling the N-PAZ and MID-PIWI lobes.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
Argonaute proteins (AGOs) load small RNA duplexes and select one strand to form the RNA-induced silencing complex (RISC), but the mechanism of assembly remains unclear. We report four cryogenic-electron microscopy structures of human AGO2 bound to a small interfering RNA (siRNA) duplex, which captures previously unanticipated intermediates. Unexpectedly, only the MID-PIWI lobe secures one duplex end, while α-helix 14 probes its stability. When the N domain reaches the opposite end, the L1 hairpin and Stalk wedge into the duplex and the PAZ domain engages the guide 3' end. This configuration peels the passenger from its 5' end while leaving it paired to the guide seed. AGO2 completely ejects the passenger by replacing it even with partially complementary target RNAs. This target-assisted passenger ejection (TAPE) also operates for the cleaved passenger strand. Our study uncovers that mRNAs are bifunctional molecules that not only serve as targets of RISCs but also help drive RISC assembly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.